You are here: Home » News-CM » Companies » Results
Business Standard

Glaxosmithkline Pharmaceuticals consolidated net profit declines 5.95% in the March 2020 quarter

Topics
Business Finance

Capital Market 

Sales rise 3.33% to Rs 775.80 crore

Net profit of Glaxosmithkline Pharmaceuticals declined 5.95% to Rs 138.07 crore in the quarter ended March 2020 as against Rs 146.81 crore during the previous quarter ended March 2019. Sales rose 3.33% to Rs 775.80 crore in the quarter ended March 2020 as against Rs 750.81 crore during the previous quarter ended March 2019.

For the full year,net profit declined 79.07% to Rs 93.20 crore in the year ended March 2020 as against Rs 445.39 crore during the previous year ended March 2019. Sales rose 3.08% to Rs 3224.38 crore in the year ended March 2020 as against Rs 3128.12 crore during the previous year ended March 2019.

ParticularsQuarter EndedYear EndedMar. 2020Mar. 2019% Var.Mar. 2020Mar. 2019% Var.Sales775.80750.81 3 3224.383128.12 3 OPM %22.3721.71 -20.3819.21 - PBDT187.87215.62 -13 729.92702.56 4 PBT165.28201.94 -18 647.24653.97 -1 NP138.07146.81 -6 93.20445.39 -79

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, May 18 2020. 19:15 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU